Infection and Immunity, November 2000, p. 6115-6126, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Center for Vaccine Development and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 212011; Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla, Pue., Mexico2; Department of Biology, Reed College, Portland, Oregon 972023; Center for Biotechnology, Northwestern University, Evanston, Illinois 602014; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 207425; and Illumina Inc., San Diego, California 921216
Received 11 April 2000/Returned for modification 26 June 2000/Accepted 7 August 2000
| |
ABSTRACT |
|---|
|
|
|---|
Regulation of virulence gene expression in enteropathogenic
Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) is incompletely understood. In EPEC, the
plasmid-encoded regulator Per is required for maximal expression
of proteins encoded on the locus of enterocyte effacement (LEE), and a
LEE-encoded regulator (Ler) is part of the Per-mediated regulatory
cascade upregulating the LEE2, LEE3, and
LEE4 promoters. We now report that Ler is essential for the
expression of multiple LEE-located genes in both EPEC and EHEC,
including those encoding the type III secretion pathway, the secreted
Esp proteins, Tir, and intimin. Ler is therefore central to the process
of attaching and effacing (AE) lesion formation. Ler also regulates
the expression of LEE-located genes not required for AE-lesion
formation, including rorf2, orf10,
rorf10, orf19, and espF, indicating
that Ler regulates additional virulence properties. In addition, Ler
regulates the expression of proteins encoded outside the LEE that are
not essential for AE lesion formation, including TagA in EHEC and EspC
in EPEC.
ler mutants of both EPEC and EHEC show altered
adherence to epithelial cells and express novel fimbriae. Ler is
therefore a global regulator of virulence gene expression in EPEC and EHEC.
| |
INTRODUCTION |
|---|
|
|
|---|
Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) are important enteric pathogens for humans. EPEC is the most common bacterial cause of diarrhea in infants (35), while EHEC, especially those of serotype O157:H7, are important emerging pathogens causing diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome (35). Central to the pathogenesis of both EPEC and EHEC infections is the formation of attaching and effacing (AE) lesions on infected host intestinal epithelial cells. The AE lesion is characterized by the loss of microvilli (effacement) and the induction of a pedestal of polymerized actin and other cytoskeletal elements that forms underneath and around the infecting bacterium (13, 24, 35). In EPEC strain E2348/69, the AE phenotype is encoded by a 35.6-kb pathogenicity island, the locus of enterocyte effacement (LEE) (31, 32). The LEE contains genes encoding an outer membrane protein (intimin), a type III secretion system (Esc, Sep, and Ces proteins), secreted proteins (Esp), and the translocated intimin receptor (Tir), as well as a number of open reading frames of undetermined function (8). These genes are also found in the same organization on the LEE of EHEC (36) and are necessary but not sufficient for AE lesion formation by EHEC in vitro (11).
In addition to the LEE pathogenicity island and the AE phenotype, other parts of the genome in both EPEC and EHEC encode additional virulence factors and pathogenic mechanisms. The EPEC virulence plasmid encodes the regulator Per (18) and the type IV bundle-forming pili (BFP) (16), which are necessary both for in vitro EPEC adherence to HEp-2 cells in the characteristic localized-adherence pattern and for full virulence in humans (2). The EHEC virulence plasmid encodes a large number of known or potential virulence factors (4) including an RTX cytotoxin-hemolysin, Hly, and the autotransporter toxin, EspP (3), and contains tagA, which encodes a lipoprotein homologous to the cryptic ToxR-activated TagA of Vibrio cholerae. The EHEC, but not EPEC, chromosome contains phages encoding Shiga toxins 1 and/or 2, which are central to the pathogenesis of both hemorrhagic colitis and hemolytic-uremic syndrome (35). The EPEC chromosome contains an additional small pathogenicity island encoding the autotransporter toxin EspC (43; J. L. Mellies, F. Navarro-Garcia, J. P. Nataro, and J. B. Kaper, submitted for publication).
The way in which EPEC and EHEC regulate the expression of these multiple virulence genes is not well understood, and regulation studies have been largely confined to BFP and the LEE-encoded genes. It has been shown that BFP (16) and EspC (26) (in EPEC) and the LEE-encoded Esps (26) are maximally secreted when bacteria are grown in tissue culture media. The genetic basis for regulation has focused, in EPEC, on the role of the plasmid-encoded regulator, Per (18), which upregulates the expression of BFP and the LEE-encoded genes in EPEC (18, 33, 44). An analogous specific regulator has not been described for EHEC. It has recently been demonstrated that quorum sensing is also involved in the regulation of EHEC and EPEC LEE genes (42).
In contrast to EPEC and EHEC, much more is known about regulation in related pathogens and other type III secretory systems (reviewed in references 7 and 21). A common theme is gene activation by an AraC-like protein and repression with a second DNA binding protein such as YmoA (in Yersinia) or H-NS. H-NS, the "histone-like nonstructural protein," binds strongly to curved (i.e., usually AT-rich) DNA, causing changes in supercoiling and packing and influencing gene expression (7, 21). In Shigella, H-NS counters the upregulatory effect of VirF and represses transcription of virB, while in enterotoxigenic E. coli, H-NS represses CfaD-mediated activation of cfa (7). H-NS is important for flagellar synthesis, F1-fimbrial phase switching, and regulation of proU and csgA among other genes (1, 5, 7, 21). H-NS can also negatively regulate its own expression (6).
A large family of H-NS-like proteins has been described which includes orthologs such as BpH3 in Bordetella (19) and the paralogous E. coli protein StpA (40). These proteins diverge significantly from H-NS and may have a different spectrum of activity but can functionally substitute for H-NS in several assays (1).
A gene whose predicted protein product has similarity to the H-NS family of DNA binding proteins was recently found in the LEE of EPEC (8). Originally termed orf1, this open reading frame is shown here to encode a protein able to regulate virulence gene expression but to be functionally distinct from H-NS. We recently reported that orf1 in EPEC is part of a regulatory cascade involving the AraC homolog Per and renamed this gene ler (for "LEE-encoded regulator") (33). ler was found to activate the transcription of several LEE operons. Another group has also recently found that ler can activate transcription from LEE operons and is required for expression of LEE-encoded proteins (14). They also demonstrated that integration host factor binds upstream of ler and is required for Ler expression.
We report here that ler also regulates LEE genes in EHEC O157:H7 and, more surprisingly, affects the expression of phenotypes encoded elsewhere in the genome of both EPEC and EHEC O157:H7. These results expand the role of Ler as a global regulator of virulence gene expression in both EPEC and EHEC.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, plasmids, and PCR primers.
Bacterial
strains and plasmids used in this study are listed in Table
1, and PCR primers are listed in Table
2. Unless otherwise stated, bacteria were
grown at 37°C in Luria broth. In experiments where minimal essential
medium (MEM; Life Technologies, Bethesda, Md.) was used, bacteria were
grown overnight at 37°C in MEM prior to inoculation into fresh MEM
and grown until an optical density at 600 nm of 1.0 (late log phase)
was reached. The growth medium was supplemented with ampicillin (200 µg/ml), chloramphenicol (25 µg/ml), kanamycin (25 µg/ml), or
nalidixic acid (100 µg/ml) as needed.
|
|
Molecular techniques. Where cloning required PCR amplification, the proofreading polymerase Pwo (Boehringer-Mannheim) was used and the resultant clones were examined for fidelity by sequencing. All other PCR amplifications were performed using Taq polymerase (Life Technologies). Automated sequencing was performed at the University of Maryland Biopolymer Core Facility. All other molecular techniques were performed by standard methods. DNA analysis was performed with DNAsis v5 (Hitachi) and with the suite of programs provided by the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov). Homology searches were performed using PSI-BLAST (http://www.ncbi.nlm.gov/blast/psiblast.cgi) with the filter off and gap function activated. Protein localization was predicted using the PSORT algorithm (http://www.psort.nibb.ac.jp).
Cloning and mutagenesis. The ler regions from EPEC and EHEC were cloned into a variety of vectors. pCVD456 (31) is a 3.1-kb EcoRI fragment from the LEE of EPEC E2348/69 cloned into pMOB and containing ler orf2345. Primers K1372 and K1420 were used to amplify ler from the EPEC chromosome, which was cloned into pBR322 digested with EcoRI and BamHI, creating pSE1100. pSE1092 was constructed by amplification of the ler region from EHEC 85-170 using primers K1372 and K1370 and cloning as an EcoRI-blunt fragment into an EcoRI-PvuII fragment of pACYC184. In all cases the ler region was transcriptionally isolated from plasmid promoters, since we observed that clones containing ler under the control of a strong plasmid promoter grew poorly and the plasmid was unstable.
A nonpolar in-frame deletion mutation of ler was constructed in both EPEC E2348/69 and EHEC O157:H7 strains by allelic exchange. For EPEC, primers K590 through K593 were used to amplify ca. 500-bp regions flanking ler which contained a SmaI site at the deletion junctions into which was cloned the promoterless kanamycin resistance cassette, aphA3 (hereafter referred to as kan). This fragment, containing the EPEC ler promoter upstream and the resistance cassette and orf2 downstream, was initially cloned as an EcoRI-BamHI fragment in pBluescript and was then moved as a PvuII fragment into the suicide vector pJG9. pJG9 contains a temperature-sensitive replicon and sacB gene for counter selection. The resultant plasmid, pSE774, was electrotransformed into E2348/69, and, via allelic exchange, the wild-type chromosomal ler gene was replaced with an in-frame, nonpolar kan cassette, generating strain SE796. The site of insertion was confirmed by PCR and Southern hybridization. To construct a ler mutation in the LEE of EHEC, primers K1370 through K1373 were used to PCR amplify and ligate regions flanking ler from the chromosome of EHEC strain 85-170, using a strategy similar to that employed for pSE774. The ultimate construct of pSE1096 was used to mutate the ler gene on the EHEC chromosome, as was previously done with EPEC. The mutation was confirmed with PCR and by sequencing the flanking regions. pSE1096 was used to mutate ler in EHEC O157:H7 strain 85-170, generating SE1099, and strain 86-24, generating SE1101. The ler regions in both these strains are identical to that of EDL933. The mutant phenotypes exhibited by SE1099 and SE1105 were complemented by cloned ler.Primer extension.
Primer extension was performed as
described previously (33). Briefly, primers hybridizing to
the sense strand between 20 and 50 nucleotides downstream of the ATG
start codon were end labeled using T4 DNA kinase and
[
-32P]ATP. Labeled primers were hybridized with 35 µg of DNA-free total bacterial RNA and reverse transcribed for 1 h at 42°C using Life Technologies Superscript II reverse
transcriptase and the recommended buffers, reagents, and methods. The
resultant cDNA mix was treated with RNase H, precipitated, and resolved
through a 6% acrylamide-urea sequencing gel, and the bands were
visualized by autoradiography.
Assays for virulence-associated phenotypes. The fluorescent actin stain (FAS) test (27) utilizes fluorescein isothiocyanate-phalloidin to visualize the accumulation of actin beneath and around bacteria attached to HEp-2 cells. A weak or unfocused accumulation of actin underneath bacteria appears as a faint halo of fluorescence known as the shadow phenotype (27). The assay for Tir translocation has been previously described (38). EspA filaments were visualized using anti-EspA antibodies and immunofluorescence microscopy, as described previously (28). Expression of bacterial proteins was examined in supernatants and purified membrane and cytoplasmic fractions prepared as outlined previously (9, 23). Following separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, proteins were either stained with Coomassie blue or blotted to polyvinylidene difluoride and Western blotted with monospecific polyclonal rabbit antibodies against Tir, intimin, and all EPEC secreted proteins as previously described (9, 23).
Adherence was examined by the modified method of Scaletsky et al. (40) as previously described (10). Shiga toxin production was assessed by quantitative killing of Vero cells as previously described (15). Bacterial motility was examined in Craigie tubes containing 0.25% agar in Luria broth. Fimbriae were examined by electron microscopy on negatively stained bacteria as previously described (17).Assessing promoter activity with lacZ fusions.
To assay the effect of ler on gene expression, regions
containing the promoter and at least 200 bp of flanking DNA were
amplified with Pwo polymerase and cloned into plasmid
pRS551, which contains a promoterless lac operon
(41). To generate single-copy lacZ fusions, these
plasmids were linearized with XhoI and the linear DNA was
transformed into E. coli K-12 strain TE2680 and integrated into the chromosome as previously described (12). Promoter
activity (in Miller units) was assayed by quantification of
-galactosidase activity in bacterial cultures as previously
described (34). For promoters from the EHEC LEE,
bla and stx, we used previously constructed
fusions (33, 42). New promoter fusions were constructed with
the following primers: bfp (K1546 and K1548),
espC (K1948 and K1939), tagA (K1944 and K1945),
espP (K1942 and K1943), and hly (K1502 and K1503).
Examination of Ler for properties similar to those of H-NS.
To examine if ler is functionally related to hns,
we examined the ability of ler to rescue and/or interfere
with hns function by using lacZ reporter strains
as described by Donato et al. (5). pCVD456, containing
ler orf234, or pTHK113, containing hns, was transformed into THK60 (hns+
proU::lacZYA), THK62
(
hns::tet
proU::lacZYA), THK88 (hns+
fimB::lacZYA), and THK90
(
hns::tet fimB::lacZYA) and
assayed for
-galactosidase activity (in Miller units) as described above.
| |
RESULTS |
|---|
|
|
|---|
Characterization of ler and the ler gene
product.
ler, previously known as orf1, is the
first in a series of codirectional genes in the LEE (Fig.
1). It has been recently demonstrated by
reverse transcription-PCR that these genes form a polycistronic operon
denoted LEE1 in EPEC O127:H6 strain E2348/69
(33). The LEE1 operon contains nine genes,
ler orf2345 escRSTU, and is highly conserved with respect to
EHEC O157:H7 (36). Primer extension has demonstrated
that the promoter for LEE1 in EPEC is different from that in
EHEC O157:H7 and is 169 nucleotides upstream (33, 36),
although the region upstream of ler is conserved. Alignment of these two regions demonstrated the duplication of a 6-nucleotide (ATAAGG) sequence in EPEC O127:H7 compared to the same
region in O157:H7 strain EDL933 (Fig. 1). This duplication in EPEC
falls in the region predicted as the
10 region for the
LEE1 promoter in O157:H7, disrupting this corresponding area
in EPEC. This duplication may be responsible for the inactivity of the
downstream promoter in EPEC.
|
|
Mutation of ler disrupts functions associated with the LEE. An in-frame nonpolar deletion mutation of ler was constructed in EPEC O127:H6 and both stx+ and stx strains of EHEC O157:H7, as described in Materials and Methods. For biosafety reasons, the stx EHEC strain was used for all experiments unless otherwise stated.
EPEC and EHEC
ler mutants were defective in the formation
of AE lesions on HEp-2 cells as determined by the FAS test (Table 3). EHEC
ler mutants were
negative in the FAS assay, and a shadow FAS phenotype was observed
after 6-h incubations of EPEC
ler on HEp-2 cells (data
not shown) which suggests that the ability to form AE lesions was not
completely abolished in this strain but was, rather, strongly
diminished. The FAS phenotype in both EPEC and EHEC mutants was
restored by complementation with ler from their respective
parent strains cloned on a multicopy plasmid vector (Table 3), and
complemented strains exhibited a FAS reaction that was visibly enhanced
over that of the wild type. Interestingly, the cloned EHEC
ler was also able to restore FAS in the EPEC
ler mutant (Table 3), indicating that EHEC ler
is able to functionally substitute for EPEC ler.
|
ler mutant, and complemented strains revealed that ler is necessary for EPEC and EHEC to
secrete Esp proteins into the supernatant (Fig.
3A) and for production of the EspA
filament by EPEC, since the filament was not observed in mutant strains
(Stuart Knutton, personal communication). Similarly, Tir was not
secreted by the ler mutants (Fig. 3B) and was not translocated by EPEC
ler into HEp-2 cells as determined
by staining HEp-2 cell lysates with antiphosphotyrosine antibodies
(data not shown). Immunoblotting of membrane preparations demonstrated
that intimin levels were markedly reduced in the absence of
ler (Fig. 3C). In addition to the lack of Esp secretion
observed in the
ler mutants, Esp proteins were not found
at detectable levels in the whole cell as determined by Western blot
analyses performed on lysates, probed with antibodies against secreted
Esp proteins (data not shown).
|
ler mutants did not produce them, as determined by
Western blot analyses using antisera specific for EspF (Fig. 3D) (a
gift of M. Donnenberg) or rOrf2 (Fig. 3E). The antiserum raised against
EPEC EspF did not react with EHEC EspF, presumably reflecting the high
sequence divergence in EspF between EPEC and EHEC (36).
Ler affects the level of proteins encoded outside the LEE.
The
ler gene product was found to control the expression of
genes encoded outside the LEE in both EPEC and EHEC. We observed high-molecular-mass (~110 kDa) proteins in the supernatants of wild-type and complemented strains grown in MEM but not in supernatants from
ler mutants (Fig. 4A).
In EPEC, this band has been identified as EspC, an autotransported
toxin encoded by a separate chromosomal pathogenicity island
(43; Mellies et al., submitted). Western blotting
with an antiserum that recognizes EspC (22) supported this
identification (Fig. 4B).
|
ler
derivative, SE1101, when assayed on Vero cells (A. O'Brien, personal communication). Similarly, Ler did not appear to
affect the production of enterohemolysin from EHEC, as assayed on 5% washed sheep erythrocyte agar (data not shown).
Mutation of ler affects the pattern of EPEC adherence
and causes hyperadherence in EHEC.
Mutation of ler in
EPEC and especially in EHEC was associated with changes in the pattern
of adherence (Fig. 5, Table 3). Wild-type
EPEC normally exhibits localized adherence (LA) to HEp-2 cells, with
the formation of microcolonies (Fig. 5A). Mutation of ler in
EPEC was associated with the appearance of a complex-aggregative (AA)-diffuse-adherence (DA) phenotype and proportionally decreased localized adherence (LA), although some microcolonies were
observed (Fig. 5B). The differences between wild-type and
ler mutant strains were more clearly visible after a 6-h
incubation with HEp-2 cells rather than the more common 3-h incubation
period (data not shown). Complementation of the
ler
mutant with cloned ler abolished the DA-AA pattern and
restored the LA pattern (Fig. 5C).
|
ler mutant,
SE1099, was more adherent than the wild type and adhered in
an AA pattern (Fig. 5E). Transformation of SE1099 with pSE1092
(pLEREHEC) restored the wild-type adherence pattern and
abolished the AA pattern (Fig. 5F).
Mutation of ler causes the expression of novel fimbriae
in EPEC and EHEC.
Electron microscopy studies of the
ler mutants demonstrated that the alterations in
adherence observed in these strains were accompanied by changes in
fimbrial expression. In addition to the BFP normally produced by EPEC,
the EPEC
ler strain produced additional fimbriae with
novel morphologies (Fig. 6A). We clearly distinguished several morphologically distinct fimbrial types including
long fine fimbriae, more rigid bent fimbriae, and short fine fimbriae
(Fig. 6A and B). The complemented mutant, E2348/69
ler(pLER), did not express these novel fimbriae (data not
shown) and displayed the wild-type phenotype.
|
ler
strains in Western blot analyses using anti-BfpA antiserum against
whole-cell lysates of bacteria grown both in MEM and on agar (data not shown).
When we examined EHEC, we also observed that mutation of ler
was associated with enhanced fimbrial expression. Wild-type 85-170 typically expressed few fimbriae (data not shown). The
ler mutant SE1099, however, produced long fine fimbriae
(Fig. 6C) that were not observed in the wild type or the complemented
strain (data not shown). It is not yet known if these fimbriae are
identical to the morphologically similar long fine fimbriae observed in the EPEC
ler mutant. We are currently characterizing
these novel Ler-regulated fimbriae from EPEC and EHEC.
Ler activates promoters in the absence of other EPEC- or EHEC-specific genes. Ler is able to activate promoters from the LEE and elsewhere in the genome in the absence of other EPEC- or EHEC-specific genes. This was demonstrated by fusing promoters to a lacZ reporter gene and introducing them as single copies into the chromosome of E. coli K-12. These strains were then transformed with pSE1093 (pBR322 containing ler from EHEC) when the promoter was derived from EHEC or pSE1100 (pBR322 containing ler from EPEC) when the promoter was EPEC derived. Control strains containing only the pBR322 vector were also constructed and tested.
The genes within the LEE are arranged in at least five large polycistronic operons designated LEE1 through LEE4 and tir (Fig. 1), and the transcription start sites have been determined by primer extension (9, 33, 42). Using previously constructed reporter fusions (9, 42), we demonstrated that Ler upregulated transcription from EHEC LEE promoters for the tir, LEE2, and LEE3 operons in the range of about eightfold (Table 4). These data demonstrate that Ler upregulates the expression of several virulence-associated proteins and demonstrate that Ler acts directly as an activator of transcription of LEE operons from EHEC and EPEC, including those containing esc/sep and tir. Ler did not regulate PLEE1 (i.e., the ler promoter) or eae, indicating that intimin expression is controlled via the tir promoter, which regulates the tir cesT eae polycistronic operon. Similar results have been previously reported by us for EPEC LEE operons LEE1, LEE2, and LEE3 (33). Interestingly, Ler did not regulate the LEE4 operon in EHEC and caused only a twofold upregulation of the LEE4 operon in EPEC (33). The observation that Ler is, at best, a weak activator of the LEE4 promoter contrasts with the dramatic increase in EspABD protein levels in the presence of Ler (Fig. 3).
|
Primer extension identifies additional genes regulated by Ler in
wild type EPEC and EHEC.
Primer extension was used to find whether
particular mRNA transcripts were synthesized in EPEC and EHEC in either
the presence or absence of Ler. We have previously (33) used
primer extension to demonstrate that Per upregulates the
LEE1 and (via Ler) LEE2 transcripts. We now
report that Ler is absolutely necessary for full transcription of the
LEE4 operon in both EPEC and EHEC (Fig. 7), supporting our observations that
levels of EspADB and EspF are markedly reduced in
ler
mutants. This finding is in contrast with data from
LEE4::lacZ reporters in an E. coli
K-12 background and strongly implies the presence of a specific
LEE4 regulator that is present in EPEC and EHEC but not
K-12.
|
Ler is distinct from H-NS.
Alleles of H-NS may have divergent
amino acid sequences but nonetheless be able to functionally substitute
for H-NS in hns mutant strains, as has been observed with
BpH3 (19), StpA (40), and others (1).
At the same time, some H-NS homologs, such as StpA, form heterodimers
with H-NS that may affect the normal DNA binding properties of H-NS,
and so StpA action is more fully understood in an
hns+ background (6). We examined to
what extent Ler might be functionally analogous to H-NS or whether Ler
could alter H-NS activity by using reporter fusions of lacZ
to either proU or fim (5).
hns+ and hns fusion strains were
transformed with pCVD456 (ler) or pTHK113 (hns).
We found that while cloned H-NS affected the expression of
proU::lacZ or
fim::lacZ up to 18-fold (Table
5), Ler had less than a 2-fold effect,
which we do not consider significant. Therefore, Ler is neither
functionally equivalent to H-NS nor able to have dominant negative
effects on H-NS function.
|
ler mutants was not diminished from that of the wild type
as assessed in the Craigie tube, semisolid agar, and hanging-drop
methods (data not shown). The results of all of these experiments
indicate that Ler is functionally distinct from H-NS.
| |
DISCUSSION |
|---|
|
|
|---|
The ler locus encodes a regulator of virulence gene expression in both EPEC and EHEC O157:H7, directly regulating genes within the LEE elements and elsewhere in the genome. ler was originally described as orf1 and was proposed as a DNA binding protein on the basis of homology to the H-NS family of regulators (8, 30). Once it was demonstrated that the locus fulfills the functions of a regulator by activating transcription of LEE operons, it was renamed ler, the LEE-encoded regulator (33).
Ler is essential for the formation of AE lesions, since all the genes
known to be important for AE lesion formation are regulated by
ler or, in the case of the LEE1 operon,
coregulated with ler. Both EPEC O127:H6 and EHEC O157:H7,
with nonpolar deletions of ler, were unable to form AE
lesions on HEp-2 cells, form the EspA filament, express intimin,
translocate Tir, or secrete into the supernatant the type III secreted
proteins EspA, EspB, EspD, or Tir. In addition,
ler
mutants failed to express the type III secreted proteins, in contrast
to mutants with mutations in escN or some other genes
involved in type III secretion, which produce Esp and Tir proteins
normally but are unable to secrete or translocate these proteins
(9, 22, 23, 47). Therefore, the
ler phenotype is consistent with Ler as a regulator of LEE-located genes. Ler was
then directly demonstrated to act as a regulator able to activate the
transcription of LEE promoters in the absence of other EPEC- or
EHEC-specific genomic elements with the use of lacZ reporter fusions in an E. coli K-12 background. This has been
demonstrated for several EPEC promoters (33), and we have
now demonstrated it for EHEC LEE promoters, including that of
tir.
The level of induction observed in a K-12 background for
LEE2,3 and tir promoters, from both EPEC and
EHEC, was ca. eightfold. It is possible that induction of these operons
is more dramatic in the wild-type strain due to contributions of
accessory factors, modifications of Ler, or loss of topological
features in the single-copy fusions. This is clearly the case with the
promoter for LEE4. In a K-12 background, LEE4 is
strongly expressed in the absence of Ler and is induced at most twofold
by Ler. In a wild-type background, by contrast, LEE4 is not
expressed in
ler mutants and is strongly induced by Ler,
as assessed from the levels of EspADBF proteins and from primer
extension experiments. This implies both the presence of EPEC- and
EHEC-specific accessory factors and the normal repression of
LEE4 in the wild type. Further, it suggests that an
accessory factor normally represses LEE4 and that Ler may
function as a derepressor of expression from this operon. For example,
lack of type III secretion may feed back to inhibit transcription.
While Ler is clearly responsible for regulating the expression of the elements involved in the AE phenotype, it also regulates other LEE-encoded factors not involved in AE lesion formation. Based on primer extension, Ler increased transcription from rorf2, orf10, rorf10, orf19, escD, and LEE4 operons. From the operon structure of the LEE (8, 33), this also predicts increased transcription of rorf1, orf11, and orf27 through espF. We observed increased levels of rOrf2 and EspF proteins in strains containing Ler, consistent with the results predicted from primer extension. Ler therefore is potentially able to activate the entire LEE.
Our findings compare with those recently published by Friedberg et al. (14) who screened, in an EPEC background, a multicopy plasmid library containing random fragments of the EPEC LEE fused to a gfp reporter. They demonstrated that Ler was necessary for production of EspADB, Tir, intimin, and EspF and could activate promoters for LEE2, LEE3, and eae in the range of 5- to 44-fold. They found that Ler did not activate rorf2, nor did they find evidence that LEE4 or other LEE genes were activated by Ler. While the use of reporter fusions in a wild-type background has certain advantages, our laboratory has found that the use of multicopy plasmids containing strong promoters fused to a toxic protein such as green fluorescent protein in a RecA+ background may mislead. For example, highly expressed genes may be toxic in this system and cannot be cloned, and so they are missed in a genetic screen. Furthermore, DNA topology is an important factor in the function of H-NS-like proteins, and studying regulation of a chromosomal gene cloned into a multicopy plasmid may result in misleading conclusions (such as the level of activation) due to differences in DNA topology between supercoiled plasmids and chromosomal genes. Consequently, we continue to use stable, chromosomally integrated fusions to the nontoxic lacZ reporter and support or extend our findings with Western blots, primer extensions, and other assays of activity in the wild-type host. We believe that the differences observed in the levels of activation between the two studies and the failure of Friedberg et al. (14) to observe Ler activation of rorf2, orf10, rorf10, orf19, escD, and LEE4 reflect differences in methodology.
In addition to the effects of Ler on LEE-located genes, we found that Ler regulates the expression of phenotypes and proteins encoded outside the LEE. We observed that Ler strongly activates (31-fold) the espC promoter and increases the levels of EspC secreted from EPEC. The 110-kDa secreted protein EspC is encoded on a second chromosomal pathogenicity island in EPEC and has recently been demonstrated to be an enterotoxin in vitro (Mellies et al., submitted). The homologous EHEC O157:H7 protein EspP has been identified in EHEC culture supernatants and is encoded on the EHEC virulence plasmid. We observed that Ler regulated the levels of a large secreted protein(s) from EHEC but could not demonstrate Ler activation of an espP::lacZ fusion in K-12 or activation of espP transcription in the wild type. This suggests that Ler regulates another, as yet unidentified autotransporter and that the protein observed in EHEC 85-170 supernatants is not EspP. Another gene carried on the EHEC plasmid, tagA (4), was, however, regulated by ler, as judged by tagA::lacZ fusions in K-12. tagA has no known function in EHEC or in V. cholerae, where it was first described as a ToxR-activated protein. It is interesting that the function of TagA remains cryptic yet it is activated by major virulence regulons in two unrelated enteric pathogens.
Ler also regulates fimbrial expression and adherence phenotypes. In
EHEC, mutation of ler was associated with enhanced adherence to tissue culture monolayers, altered adherence patterns, and expression of long fine fimbriae (LFF). These parallels suggest that
Ler is a repressor of LFF (or perhaps an activator of another repressor) and that these fimbriae mediate the DA-AA pattern of adherence observed in vitro. No fimbrial adhesin has yet been clearly
defined for EHEC O157:H7, and we are conducting further investigation
into the identity and properties of these fimbriae. It should be noted
that it is difficult to determine the roles of particular Ler-regulated
fimbriae in altered adherence phenotypes since other factors involved
in adherence, such as intimin and the type III secretion system, are
not expressed in
ler strains.
The EPEC
ler mutant exhibited a mixture of both DA-AA and
LA to HEp-2 cells, while the wild type and the complemented strain exhibited LA. Electron microscopy demonstrated that the EPEC
ler mutant expressed a number of fimbriae of morphologic
types not observed in the wild type and not previously described in
EPEC or EHEC. These fimbriae in EPEC were unrelated to BFP since they were expressed under conditions normally nonpermissive for BFP production, they were demonstrated by immunoelectron microscopy to be
distinct from BFP, and both Western blots and
bfp::lacZ fusions demonstrated that Ler does
not regulate BFP production. We are currently characterizing these
novel fimbriae, and it is possible that the LFF observed in the EPEC
ler are identical to those observed in EHEC
ler and may represent a common EPEC and EHEC adhesin
mediating DA-AA adherence to HEp-2 cells.
Ler therefore can have both negative and positive effects and thereby
can play a central role in regulating many virulence and
virulence-related phenotypes including AE lesion formation, adherence,
and toxin production in both EPEC and EHEC. The fact that Ler
coregulates so many genes suggests that a number of cryptic genes may
play important roles in pathogenesis. We propose an entire
ler regulon (Fig. 8), which
suggests a pattern of gene expression in pathogenesis. Low levels of
Ler expression are associated with enhanced production of fimbriae
and/or adhesins which could be involved in initial colonization. High
levels of Ler expression are associated with upregulation of genes
involved in AE lesion formation, intimate adherence, and toxin
production. This would imply at least two distinct phases in the
regulation of virulence genes involved in pathogenesis.
|
Since Ler expression is central to regulation of virulence genes, it follows that the regulation of Ler expression is important to pathogenesis. Ler expression in EPEC is activated by Per (33) and IHF (14). Per is not present in EHEC, but there is at least one shared regulatory pathway, since we have recently shown that quorum sensing activates the LEE1 promoter in both EPEC and EHEC (42). Differences in the pathways of Ler activation reflect differences in EPEC and EHEC pathogenesis. EHEC infects the large intestine and so could potentially use autoinducer secreted by the large number of resident bacteria to signal activation of virulence gene expression. EPEC normally infects the small intestine, where the concentration of bacteria is low, and may overcome this deficit by the presence of Per, which may respond to other environmental signals.
The structure of the Ler regulon also reflects the evolutionary history of EPEC and EHEC as proposed by Whittam and McGraw (48), in which the LEE elements were inherited first and other virulence factors added to the genome in later evolution. It would appear that many of the later elements have come under the control of Ler as they have been acquired, including other virulence loci and the large virulence plasmid (in EHEC). In contrast, it would appear that in EPEC the Per regulator may have evolved on the BFP plasmid first to regulate BFP and subsequently to regulate Ler.
The mechanism by which Ler regulates the expression of these genes remains to be determined. Ler is distantly related to the H-NS family of proteins but is functionally distinct from H-NS, as demonstrated by several assays (Table 5), and neither protein can functionally substitute for the other. Therefore, while H-NS is an important global regulator of housekeeping genes, Ler appears to be specific for virulence-associated genes and is encoded in a pathogenicity island. Furthermore, Ler also appears to be different from other H-NS homologs that appear to act as antagonists or modifiers or H-NS action, since Ler could not suppress H-NS-mediated phenotypes. This suggests that Ler may represent a new member of the H-NS family of DNA binding proteins but one that is neither analogous nor antagonistic to H-NS.
| |
ACKNOWLEDGMENTS |
|---|
We thank the staff of the University of Maryland Biopolymer Laboratory for sequencing, Stuart Knutton for examination of EspA filament production, and Maria S. Dubois for assistance with protein techniques. We especially thank Gina Donato and Tom Kawula, University of North Carolina, for assistance with H-NS experiments and the laboratory of Alison O'Brien, Uniformed Services University of the Health Sciences, for Shiga toxin assays.
This research was supported by NIH grants AI21657 and AI41325.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201. Phone: (410) 706 2493. Fax: (410) 706 0182. E-mail: jkaper{at}umaryland.edu.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bertin, P., N. Benhabiles, E. Krin, C. Laurent-Winter, C. Tendeng, E. Turlin, A. Thomas, A. Danchin, and R. Brasseur. 1999. The structural and functional organization of H-NS-like proteins is evolutionarily conserved in gram-negative bacteria. Mol. Microbiol. 31:319-329[CrossRef][Medline]. |
| 2. |
Bieber, D.,
S. W. Ramer,
C. Y. Wu,
W. J. Murray,
T. Tobe,
R. Fernandez, and G. K. Schoolnik.
1998.
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.
Science
280:2114-2118 |
| 3. | Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 24:767-778[CrossRef][Medline]. |
| 4. |
Burland, V.,
Y. Shao,
N. T. Perna,
G. Plunkett,
H. J. Sofia, and F. R. Blattner.
1998.
The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7.
Nucleic Acids Res.
26:4196-4204 |
| 5. |
Donato, G. M.,
M. J. Lelivelt, and T. H. Kawula.
1997.
Promoter-specific repression of fimB expression by the Escherichia coli nucleoid-associated protein H-NS.
J. Bacteriol.
179:6618-6625 |
| 6. | Dorman, C. J., J. C. D. Hinton, and A. Free. 1999. Domain organization and oligomerization among H-NS-like nucleoid-associated proteins in bacteria. Trends Microbiol. 7:124-129[CrossRef][Medline]. |
| 7. | Dorman, C. J., and N. Ní Bhriain. 1999. Co-ordinate regulation of virulence gene expression in Escherichia coli, p. 373-399. In M. Sussman (ed.), Escherichia coli: mechanisms of virulence. Cambridge University Press, Cambridge, United Kingdom. |
| 8. | Elliott, S., L. A. Wainwright, T. McDaniel, B. MacNamara, M. Donnenberg, and J. B. Kaper. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28:1-4[CrossRef][Medline]. |
| 9. | Elliott, S. J., M. S. Dubois, S. W. Hutcheson, L. A. Wainwright, M. Batchelor, G. Frankel, S. Knutton, and J. B. Kaper. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol. Microbiol 33:1176-1189[CrossRef][Medline]. |
| 10. | Elliott, S. J., and J. B. Kaper. 1997. Role of type 1 fimbriae in EPEC infections. Microb. Pathog. 23:113-118[CrossRef][Medline]. |
| 11. |
Elliott, S. J.,
J. Yu, and J. B. Kaper.
1999.
The cloned locus of enterocyte effacement (LEE) from enterohemorrhagic Escherichia coli O157:H7 is unable to confer the attaching and effacing phenotype upon E. coli K-12.
Infect. Immun.
67:4260-4263 |
| 12. |
Elliott, T.
1992.
A method for constructing single-copy lac fusions in Salmonella typhimurium and its application to the hemA-prfA operon.
J. Bacteriol.
174:245-253 |
| 13. | Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic E. coli: more subversive elements. Mol. Microbiol. 30:911-921[CrossRef][Medline]. |
| 14. | Friedberg, D., T. Umanski, Y. Fang, and I. Rosenshine. 1999. Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol. Microbiol. 34:941-952[CrossRef][Medline]. |
| 15. |
Gentry, M. K., and J. M. Dalrymple.
1980.
Quantitative microtiter cytotoxicity assay for Shigella toxin.
J. Clin. Microbiol.
12:361-366 |
| 16. |
Girón, J. A.,
A. S. Ho, and G. K. Schoolnik.
1991.
An inducible bundle-forming pilus of enteropathogenic Escherichia coli.
Science
254:710-713 |
| 17. |
Girón, J. A.,
A. S. Ho, and G. K. Schoolnik.
1993.
Characterization of fimbriae produced by enteropathogenic Escherichia coli.
J. Bacteriol.
175:7391-7403 |
| 18. | Gómez-Duarte, O. G., and J. B. Kaper. 1995. A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infect. Immun. 63:1767-1776[Abstract]. |
| 19. | Goyard, S., and P. Bertin. 1997. Characterization of BpH3, an H-NS-like protein in Bordetella pertussis. Mol. Microbiol. 24:815-823[CrossRef][Medline]. |
| 20. | Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. Ann. Intern. Med. 109:705-712. |
| 21. |
Hueck, C. J.
1998.
Type III protein secretion systems in bacterial pathogens of animals and plants.
Microbiol. Mol. Biol. Rev.
62:379-433 |
| 22. |
Jarvis, K. G.,
J. A. Girón,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a specialized secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000 |
| 23. | Jarvis, K. G., and J. B. Kaper. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64:4826-4829[Abstract]. |
| 24. | Kaper, J. B., S. J. Elliott, V. Sperandio, N. T. Perna, G. F. Mayhew, and F. R. Blattner. 1998. Attaching-and-effacing intestinal histopathology and the locus of enterocyte effacement, p. 163-182. In J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C. |
| 25. |
Kawula, T. H., and P. E. Orndorff.
1991.
Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS.
J. Bacteriol.
173:4116-4123 |
| 26. | Kenny, B., A. Abe, M. Stein, and B. B. Finlay. 1997. Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect. Immun. 65:2606-2612[Abstract]. |
| 27. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 28. | Knutton, S., I. Rosenshine, M. J. Pallen, I. Nisan, B. C. Neves, C. Bain, C. Wolff, G. Dougan, and G. Frankel. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176[CrossRef][Medline]. |
| 29. | Levine, M. M., E. J. Bergquist, D. R. Nalin, D. H. Waterman, R. B. Hornick, C. R. Young, S. Sotman, and B. Rowe. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:1119-1122. |
| 30. | McDaniel, T. K. 1996. Ph.D. thesis. University of Maryland, Baltimore. |
| 31. |
McDaniel, T. K.,
K. G. Jarvis,
M. S. Donnenberg, and J. B. Kaper.
1995.
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. USA
92:1664-1668 |
| 32. | McDaniel, T. K., and J. B. Kaper. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399-407[CrossRef][Medline]. |
| 33. | Mellies, J., S. J. Elliott, V. Sperandio, M. S. Donnenberg, and J. Kaper. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol. 33:296-306[CrossRef][Medline]. |
| 34. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 35. |
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-201 |
| 36. |
Perna, N. T.,
G. F. Mayhew,
G. Pósfal,
S. Elliott,
M. S. Donnenberg,
J. B. Kaper, and F. R. Blattner.
1998.
Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun.
66:3810-3817 |
| 37. | Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685[Abstract]. |
| 38. | Rosenshine, I., M. S. Donnenberg, J. B. Kaper, and B. B. Finlay. 1992. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J. 11:3551-3560[Medline]. |
| 39. |
Scaletsky, I. C. A.,
M. L. M. Silva, and L. R. Trabulsi.
1984.
Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells.
Infect. Immun.
45:534-536 |
| 40. |
Shi, X., and G. N. Bennett.
1994.
Plasmids bearing hfq and the hns-like gene stpA complement hns mutants in modulating arginine decarboxylase gene expression in Escherichia coli.
J. Bacteriol.
176:6769-6775 |
| 41. | Simons, R. W., F. Houman, and N. Kleckner. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:85-96[CrossRef][Medline]. |
| 42. |
Sperandio, V.,
J. Mellies,
W. Nguyen, and J. B. Kaper.
1999.
Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli.
Proc. Natl. Acad. Sci. USA
96:15196-15201 |
| 43. |
Stein, M.,
B. Kenny,
M. A. Stein, and B. B. Finlay.
1996.
Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins.
J. Bacteriol.
178:6546-6554 |
| 44. | Tobe, T., G. K. Schoolnik, I. Sohel, V. H. Bustamente, and J. L. Puente. 1996. Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol 55:3117-3125. |
| 45. |
Tzipori, S.,
H. Karch,
I. K. Wachsmuth,
R. M. Robins-Browne,
A. D. O'Brien,
H. Lior,
M. L. Cohen,
J. Smithers, and M. M. Levine.
1987.
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.
Infect. Immun.
55:3117-3125 |
| 46. | Ueguchi, C., T. Suzuki, T. Yoshida, K. Tanaka, and T. Mizuno. 1996. Systematic mutational analysis revealing the functional domain organization of Escherichia coli nucleoid protein H-NS. J. Mol. Biol. 263:149-162[CrossRef][Medline]. |
| 47. | Wainwright, L. A., and J. B. Kaper. 1998. EspB and EspD require a specific chaperone for proper secretion from enteropathogenic Escherichia coli. Mol. Microbiol. 27:1247-1260[CrossRef][Medline]. |
| 48. | Whittam, T. S., and E. A. McGraw. 1996. Clonal analysis of EPEC serogroups. Rev. Microbiol. Sao Paulo 27(Suppl. 1):7-16. |
This article has been cited by other articles: